Back grey_arrow_rt.gif
 
Aging & Perinatally Acquired HIV
 
null.gif
 
 
  1. HIV reservoir and premature aging: risk factors for aging-associated illness in adolescents and young adults with perinatally acquired HIV - (09/25/24)
     
  2. IAS: The DoxyPEP Debate: To DoxyPEP or not to DoxyPEP? - (08/26/24)
     
  3. Medical comorbidities and lower myelin content are associated with poor cognition in young adults with perinatally acquired HIV - (07/19/24)
     
  4. IAS: What is HIV-Associated Neurocognitive Disorder (HAND) & Its Symptoms - (08/12/24)
     
  5. IAS: Unruly Natural Killer Cells May Figure in CVD Risk in HIV+ Adolescents - Mark Mascolini (08/02/24)
     
  6. IAS: Randomised placebo-controlled trial of high-dose vitamin D and low-dose calcium supplementation to improve bone density in adolescents with perinatally-acquired HIV in Southern Africa - (07/28/24)
     
  7. IAS: Neurocognitive trajectories among a young adult cohort from four African countries: associations with HIV and food insecurity - (07/28/24)
     
  8. IAS: Increased biomarkers of cardiovascular disease in a long-term survivor cohort of young adults living with perinatal HIV with virologic non-suppression or metabolic syndrome - (07/28/24)
     
  9. IAS: Vitamin D Plus Calcium Improves Bone Density in HIV Youth Who Start With Low Density - Mark Mascolini (07/28/24)
     
  10. IAS: Three CVD Markers High in 347 Young Adults With HIV in Thailand - Mark Mascolini (07/28/24)
     
  11. IAS: Multimorbidity by sex at birth among ageing (65 years and older) persons with HIV (PWH) in the Southern United States (US) - (07/28/24)
     
  12. IAS: Risk of major cardiovascular events with dolutegravir versus efavirenz-based antiretroviral therapy: retrospective cohort analyses using routine, de-identified data from South Africa - (07/28/24)
     
  13. IAS: Detailed modelling of viremia exposure does not independently predict cardiovascular disease in people with HIV - (07/28/24)
     
  14. IAS: Risk of major cardiovascular events with dolutegravir versus efavirenz-based antiretroviral therapy: retrospective cohort analyses using routine, de-identified data from South Africa - (07/28/24)
     
  15. IAS: Integrating non-communicable disease screening and treatment in antiretroviral clinics: insights from Malawi - (07/28/24)
     
  16. IAS: A pilot study assessing changes in cerebral function parameters in persons with insomnia switching integrase inhibitors - (07/28/24)
     
  17. Incidence of non-AIDS defining comorbidities among young adults with perinatally-acquired HIV in North America, 2000-2019 - (05/13/24)
     
  18. CROI: Chronic comorbidities in children and adolescents with perinatally acquired HIV infection in sub-Saharan Africa in the era of antiretroviral therapy - (03/07/24)
     
  19. CROI: Aging & Perinatally Acquired HIV: Cardiometabolic Risks and Comorbidities: Adolescents and Young Adults with Perinatally Acquired HIV - (03/07/24)
     
  20. Latent Profile Analysis of Cognitive Performance and Depressive Symptoms Among People with HIV - (02/26/24)
     
  21.  Perinatal Complications and Aging Indicators by Midlife - (01/06/16)
     
  22. Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms - (01/06/16)
     
  23. Dyslipidemia, chronic inflammation, and subclinical atherosclerosis in children and adolescents infected with HIV: The PositHIVe Health Study - (01/06/16)
     
  24. IMPACT OF MATERNAL HIV/HBV COINFECTION ON PREGNANCY AND INFANT OUTCOMES - (01/06/16)
     
  25. ESTIMATING ATHEROSCLEROTIC RISK IN SOUTH AFRICAN YOUTH WITH PERINATALLY ACQUIRED HIV - (01/06/16)
     
  26. Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults - (01/06/16)
     
  27. DECREASED MYELIN CONTENT AND COGNITIVE PERFORMANCE IN ADULTS WITH PERINATAL HIV - (01/06/16)
     
  28. PREDICTORS OF NEURODEVELOPMENT IN HIV-EXPOSED-UNINFECTED INFANTS - (01/06/16)
     
  29. MITOCHONDRIAL PROTON LEAK IN INFANTS WITH IN UTERO HIV AND ART EXPOSURE IN BOTSWANA - (01/06/16)
     
  30. SIMILAR EARLY GROWTH IN HEU AND HUU INFANTS WITH MATERNAL ART OPTIMIZATION - (01/06/16)
     
  31. GROWTH AND BONE MINERAL ACCRETION IN UGANDAN INFANTS EXPOSED TO MATERNAL HIV AND ART - (01/06/16)
     
  32. Impact of tenofovir-containing triple antiretroviral therapy (ART) on bone mineral density in HIV-infected breastfeeding women in sub-Saharan Africa - (01/06/16)
     
  33. Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate - (01/06/16)
     
  34. ASSOCIATION OF MATERNAL TDF-BASED ART WITH BONE MINERAL CONTENT IN BREASTFED INFANTS - (01/06/16)
     
  35. Subclinical cardiac disease in children with perinatally acquired HIV is associated with inflammation - (01/06/16)
     
  36. Cerebral injury in perinatally HIV-infected children compared to matched healthy controls....adults too - (01/05/16)
     
  37. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study - (01/05/16)
     
  38. Perinatal HIV in the brain - Editorial - (01/06/16)
     
  39. IAC: Subcortical brain volumes of children who are HIV-exposed and uninfected in the first three years of life: a South African birth cohort study - (08/02/22)
     
  40. Suicide Attempts Young HIV Perinatally Infected or Exposed - (12/05/22)
     
  41. Dyslipidemia Among Perinatally HIV-Infected Children Enrolled in the PACTS-HOPE Cohort, 1999-2004 - (12/05/22)
     
  42. Bone Quality in Perinatally HIV-Infected Children: Role of Age, Sex, Growth, HIV Infection, and Antiretroviral Therapy - (12/05/22)
     
  43. White matter of perinatally HIV infected older youths shows low frequency fluctuations that may reflect glial cycling - (12/05/22)
     
  44. Perinatally HIV-Infected Youth Presenting with Acute Stroke: Progression/Evolution of Ischemic Disease on Neuroimaging - (12/05/22)
     
  45. PERINATAL HIV-1 TRANSMISSION IN FRANCE: U=U FOR MOTHERS ON ART FROM CONCEPTION - (12/05/22)
     
  46. Growth of infants with perinatal exposure to maternal DTG vs EFV and TDF vs TAF: the randomized IMPAACT 2010 trial - (12/05/22)
     
  47. SERUM BIOMARKERS IDENTIFY CARDIAC DYSFUNCTION IN YOUTH LIVING WITH HIV - (12/05/22)
     
  48. Brief Report: Youth Living With Perinatally Acquired HIV Have Lower Physical Activity Levels as They Age Compared With HIV-Exposed Uninfected Youth - (12/05/22)
     
  49. Chronic comorbidities in children and adolescents with perinatally acquired HIV infection in sub-Saharan Africa in the era of antiretroviral therapy - (12/05/22)
     
  50. Echocardiographic Follow-up of Perinatally HIV-infected Children and Adolescents - (12/05/22)
     
  51. Decreased Myelin Content and Cognitive Performance in Adults with Perinatal HIV - (12/05/22)
     
  52. Central Nervous System Impact of Perinatally Acquired HIV in Adolescents and Adults: an Update - (12/05/22)
     
  53. Associations Between Central Obesity and Lifelong Antiviral Therapy in Adults Living With HIV Acquired From Early Childhood - (12/05/22)